chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in the arm where shot given, headache, tired day of the vaccine and next day.  arm bruised the next day. Two days after vaccine developed a rash on my left arm.   Rash has continued to get worse.  The rash started out small with small bumps that itch.  The bumps progressed into painful and developed blisters.  The blisters last a couple of days then peel.  The area remains red where the rash was.  The reaction has progressed to my neck, torso, legs, back, both arms.   I started out using calamine lotion to ease the itch.  After6 days, I stopped by the local Pharmacy .  I spoke to a male pharmacist.  I showed him my arm.  He recommended Cortizone 10 creme and Benadryl.  I have been using this for 6 days.  The rash that started originally on my upper arm is finally starting to show signs of improvement.  However, the rest of me is not.  I will note that I did online research and read multiple articles, particularly one from a hospital in another state.  The article indicated that their study found this same reaction in patients--particularly women .  Their study noted the rash lasted anywhere from 8 days to 14 days.  Seeing this, I didn't get alarmed with my reaction.  It is just aggravating and uncomfortable to me.
staph infection around the same time as getting the vaccine; Skin Sores looking like Chickenpox (Majority on Torso and groin area); Painful and Swollen Lymph Nodes (Groin and Arm pit ); Malaise; Sore left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of STAPHYLOCOCCAL INFECTION (staph infection around the same time as getting the vaccine) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced MALAISE (Malaise) and ARTHRALGIA (Sore left shoulder). On 26-Mar-2021, the patient experienced SKIN LESION (Skin Sores looking like Chickenpox (Majority on Torso and groin area)) and LYMPHADENOPATHY (Painful and Swollen Lymph Nodes (Groin and Arm pit )). On an unknown date, the patient experienced STAPHYLOCOCCAL INFECTION (staph infection around the same time as getting the vaccine) (seriousness criterion medically significant). On 23-Mar-2021, MALAISE (Malaise) and ARTHRALGIA (Sore left shoulder) had resolved. At the time of the report, STAPHYLOCOCCAL INFECTION (staph infection around the same time as getting the vaccine) outcome was unknown and SKIN LESION (Skin Sores looking like Chickenpox (Majority on Torso and groin area)) and LYMPHADENOPATHY (Painful and Swollen Lymph Nodes (Groin and Arm pit )) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: New adverse event; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a medical assistant concerning an 14 year old patient of unknown gender. Medical history or concurrent conditions were not reported. On 21-AUG-2014, the patient was vaccinated with improperly stored GARDASIL, (Lot number K001500; Expiration date: 16-NOV-2016) (dose, frequency, strength not provided). Co-suspect or concomitant therapies were not reported. This is one of several reports from the same source. Additional information has been requested.
Patient received vaccine Thursday morning. Later that evening, he started experiencing chills, fever (>101F), and body aches for the next couple of days. Saturday morning, fever continued with body aches throughout the day but other symptoms subsided. Chest pain started Saturday evening but patient was unsure what it was. Saturday after midnight, patient went to sleep and woke up after 30 mins with chest pain, chest pressure, burning sensation in chest, and stiff neck. Patient couldn't lay down in bed and went to ED.
sharp Pain and is traveling up to the left shoulder; Soreness at the injection site /the sensation is now a sharp Pain and is traveling up to the left shoulder; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th January 2021, the patient received Shingrix (intramuscular). On 6th January 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On 12th January 2021, the patient experienced shoulder pain. On an unknown date, the outcome of the pain in arm and shoulder pain were unknown.   It was unknown if the reporter considered the pain in arm and shoulder pain to be related to Shingrix.  Additional details were reported as follows: The reporter was patient's daughter. The patient received Shingrix and on the same day, had soreness at the injection site and now that sensation was a sharp pain and 6 days  after receiving Shingrix, was traveling up to the left shoulder. The reporter did not consent to follow-up.
felt nausea/vomiting a few mins after getting vaccine. pt has prior hx of feeling similar symptoms in the past from other shots especially when she doesn't eat. only had coffee this morning
4 inch x 4 inch area of induration surrounding vaccine site present 1 week after administration. No s/s infection, will monitor.
Tinnitus and inner ear pain began. At first I thought maybe due to Trintellix and/or Wellbutrin XL, but I've taken both of those off and on for 4+ years each. I had recently added the Wellbutrin to Trintellix so that is why I first assumed that, in in light of vaccine tinnitus, and timeline that makes more sense.  I went to 2 ENT's who just wrote me off. They said I have hearing loss too.  I have never had any ear or hearing problems until end of 2021.  I did not have hearing problems at 1st or 2nd COVID-19 vaccinations.  The problem has not gone away, lessened, or worsened (although the level has been about higher mid-level as far as discomfort/disruption to my life).
she noticed a rash in both arms, legs and the back/ Rash (inflammation and redness)/ eliminated the rash but not the redness generated by it; Fever; Flue like symptoms; Sore throat; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flue like symptoms), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches), RASH (she noticed a rash in both arms, legs and the back/ Rash (inflammation and redness)/ eliminated the rash but not the redness generated by it) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021 at 8:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flue like symptoms), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and PYREXIA (Fever). On 20-Nov-2021, the patient experienced RASH (she noticed a rash in both arms, legs and the back/ Rash (inflammation and redness)/ eliminated the rash but not the redness generated by it). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flue like symptoms), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown and RASH (she noticed a rash in both arms, legs and the back/ Rash (inflammation and redness)/ eliminated the rash but not the redness generated by it) had resolved with sequelae.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  She took some Benadryl worked and eliminated the rash but not the redness generated by it.
Covid-19 treatment; Covid-19 treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received BNT162b2 (BNT162B2), on 11Nov2021 at 16:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 30 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "not recovered" and all described as "Covid-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient had no known allergies. The patient did not receive other medication in two weeks. Vaccine administration date: 31Nov2021 (as reported). Vaccine administration time: 04:00 PM. Anti-viral details for COVID 19 treatment included Paxlovid (Treatment start date: 15Jul2022, Treatment stop date: 19Jul2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient called on 11/10 stating the site around the injection site was painful to touch, swollen, warm, and a rash was appearing on her arm and spreading around the injection site. The swelling was also spreading out from the injection site.
have been waking up at 12 o'clock or 1 o'clock and be wide awake; red and rashy; the knot was still there; a rash down my arm; it got itchy; arm was sore; A spontaneous report  was received from a Consumer concerning a 68-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was sore, it got itchy, red and rashy, the knot was still there, 2-inch circle around it, a rash down my arm, have been waking up at 12 o'clock or 1 o'clock and be wide awake.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 14 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 013220A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 14 Jan 2021, the patient experienced the events arm was sore . On 21 Jan 2021, the patient experienced the events it got itchy . On 22 Jan 2021, the patient experienced the events red and rashy. the knot was still there, 2-inch circle around it, a rash down my arm. On an unknown date, the patient experienced the events have been waking up at 12 o'clock or 1 o'clock and be wide awake.  Treatment details included Patient states using Benadryl ointment and putting ice pack on her arm.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, arm was sore, it got itchy, red and rashy, the knot was still there, 2-inch circle around it, a rash down my arm, have been waking up at 12 o'clock or 1 o'clock and be wide awake was not reported.
I have never had hives before but my wife says it seems just like it.  I have these extremely itchy areas on my body. They never show up in the same area and leave no trace after itching stops. These itchy situations show up in random areas on my body lasting for about 15 mins two or three times a day.
When I received the 2nd shot on 06/01/21 my left arm was sore and bruised, I had no other reactions.  I also had Covid prior to my injections in case you need to know.  2 days ago on the 14th my arm started hurting in the injection spot and a bruise showed up again.  There was no injury to my arem.
URINARY TRACT INFECTION; This spontaneous case report (PVX2019-2384) received from a pharmacist on 20-Sep-2019. It described a female consumer who developed urinary tract infection (UTI) (PT: Urinary tract infection), while on therapy with Vivotif for an unknown indication.  Case report: The consumer started taking Vivotif and developed urinary tract infection. She did not know the exact date when the bladder infection began, it might have started after taking Vivotif. She was prescribed ciprofloxacin (500 mg, one tablet twice daily for 10 days) for bladder infection. It was reported that the consumer was due to finish Vivotif on Saturday. The consumer had not started ciprofloxacin until the time of report.  The patient's medical history included UTI. She had no known drug allergies.  Concomitant medications included aspirin (81 mg; once daily) and inhaler ProAir HFA (albuterol sulfate; 90 mcg, 1-2 puffs every 3 or 4 hours as needed for quick relief).  Action taken with Vivotif with respect to the event was unknown.  The consumer had not recovered from the reported event.  Company's Comment: In this case, the consumer developed urinary tract infection (UTI) after starting Vivotif vaccine. Due to the fact that UTI is an infectious condition the causality of the event was assessed as unlikely with Vivotif.; Sender's Comments: Company's Comment: In this case, the consumer developed urinary tract infection (UTI) after starting Vivotif vaccine. Due to the fact that UTI is an infectious condition the causality of the event was assessed as unlikely with Vivotif.
This spontaneous report as received from a pharmacist refers to a 75 year old female patient. Pertinent medical history and drug reactions were not reported. On 17-DEC-2013, the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneous (concentration, dose and lot number were not reported). No concomitant therapy was reported. In December 2013, the patient experienced local irritation, redness, erythema, a little bit of swelling, pruritus and a little itchy at ZOSTAVAX injection site. On 20-DEC-2013, the patient was observed by pharmacist. No lab diagnostics studies were performed. No treatment was given for the events. The outcome of the events was reported as not recovered. Additional information has been requested.
Red mark on the patient's arm the size of a quarter; Stiffness in arm; My left arm was swollen; Soreness in their arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen), VACCINATION SITE PAIN (Soreness in their arm) and VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Compazine) and Allergy to vaccine (Shingles shot). Concomitant products included SIMVASTATIN (ZOCOR), METFORMIN HCL, ESTRADIOL (YUVAFEM), METOPROLOL SUCCINATE (TOPROL XL) and TRAVOPROST for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen) and VACCINATION SITE PAIN (Soreness in their arm). On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter). On 25-Feb-2021, MUSCULOSKELETAL STIFFNESS (Stiffness in arm), PERIPHERAL SWELLING (My left arm was swollen) and VACCINATION SITE PAIN (Soreness in their arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Red mark on the patient's arm the size of a quarter) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment for the events were not provided.   This case was linked to MOD-2021-235593 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Patient demographics, medical history, concomitant medications updated. Additional event was added.Start date and stop date for the events updated.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This spontaneous report as received from a consumer refers to a 60 year old female patient. The patient's medical history included hypertension. On 02-JUN-2017, the patient was vaccinated with ZOSTAVAX, subcutaneous for prophylaxis. On unknown date in June 2017, reported as 12 hours after vaccination, the patient experienced headache, folliculitis (for which the anonymous physician prescribed an unspecified antibiotic), erythema (reported as "red pimples down her legs"), rash, malaise (reported as"felt under the weather"), asthenia, dizziness and nausea. The outcome of dizziness, headache, nausea, rash, asthenia, erythema, malaise and folliculitis was reported as not recovered/not resolved. The causality assessment between the events and with ZOSTAVAX was not provided. Additional information is not expected.
Throat swelling, raspy voice, tachycardia, itching, anxiety, rash
Redness and swelling of leg--3 cm. Larger right thigh circumference than left.
Hospital Course:  1.  COVID-19 positive, given course of Paxlovid. Doubt infectious.  This could be long Covid.  Defer to ID if role of AB indicated.  Doubt superimposed infection.  Will keep in isolation, per epidemiology.  Supportive measures.  IVF. Increase prednsione 40mg/day x 5 days.  Today is day #3.   2. Sinus tachycardia, this was prior to COVID infection.  She had outpatient cardiology evaluation but due to positive COVID could not go. She has been tachy in 130s all night and during my exam.  Continue IVF. She is to see cardiology now, consult pending  On TMS. 3.  Elevated BP, wil give PRN as needed.  No formal HTN in past.  Vitals per floor protocol.  On BB now, improved.  ECHO can be done as outpatient
Patient was administered Moderna vial instead of the Bivalent booster; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient was administered Moderna vial instead of the Bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient was administered Moderna vial instead of the Bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient was administered Moderna vial instead of the Bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient was administered Moderna vial instead of the Bivalent booster).    No concomitant medications were reported.  It was reported that the patient had already received the primary vaccination series and received vaccine from Moderna vial instead of Bivalent booster dose. The reporter had a couple of vials of the primary series in stock, out of which it was administered.   No treatment details was reported.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with M-M-R II (lot # K006396, expiration date: 04-MAY-2016, route and dose were not reported). Concomitant drug was not reported. The vaccines were at 29 F for 648 minutes and 55 F for 360 minutes because of data logger issue. There was no previous temperature excursion. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Rash on chest, back, neck, and scalp that itches - using body lotion   After showering on March 15,2021 my face was bright red. That went on 5 day after every shower. I am using Benadryl (Antistamine ) it help some what.
Initial report received from a health care professional on 21 December 2007. A 15-year-old male patient with a medical history of autism spectrum disorder and a known tic disorder, had received an injection of Fluzone SV 2007-2008 and an injection of Menactra on 05 December 2007. Both vaccines were administered intramuscularly in the deltoid and the lot numbers were not reported. Approximately 48 hours after receiving the vaccines, the patient developed a new vocal tic. At the time of this report, the vocal tic persisted and the patient had not recovered.
The reaction I had to the pneumonoccocal Vaccine (PPSV -23, valent). I began to feel ill on Monday Nov 2, in the afternoon - general malaise, headache, joint aching, chills, and extreme pain at the injection site. My temp Tuesday morning, 11/3, was 99.7, rising to 101.7 in the afternoon. I continued to have fever until late Wednesday 11/4, with continued joint discomfort, general weakness, nausea, and headache . I had swelling, extreme pain (could not raise left arm over 45 degrees), injection site was hot, swollen and rash appeared. During this time I was taking arthritis strength Tylenol alternating with Duexis. I have not run a fever since Wednesday late afternoon and the injection site is improving but I continue to have fatigue and general malaise.  Fatigue and general malaise continued thru November 10.
This was my second dose which had scheduled 4 weeks apart even though it was supposed to be 3.  About 36 hours after this second shot I began having incredible pain in my feet.  (I do periodically have problems with my feet, but this episode which is still ongoing is like something I had over 10 years ago.  I couldn?t walk for a few days.  While my right foot is doing much better the pain in my left foot is debilitating.  As I am hobbling, I?ve now aggravated my left knee and hip.  I scheduled chiropractor for  April 26.
Information has been received from a physician, concerning a 19 year old female patient with a history of papilloma viral infection (26-SEP-2007), who in October 2007, was vaccinated in the upper thigh with the first dose of Gardasil (lot # not provided).  Two weeks after the vaccination, the patient developed lymphadenopathy in her inguinal area.  The patient presented to the office for evaluation, and it was determined that she had bilateral lymphadenopathy.  Diagnostic tests included a complete blood count, with normal results.  The physician indicated that the patient had no sexually transmitted diseases.  At the time of this report, the patient had recovered from the event.  Additional information has been requested.
Information has been received from a licensed visiting nurse concerning herself whose grandchild in approximately 31-DEC-2001 ("at the end of December 2001"), was vaccinated with a dose of VARIVAX (Merck). In January 2002, a classmate of her grandchild was diagnosed with chicken pox and was sent home on the school bus with the entire class. At some unspecified time after the grandchild exposure to her classmate, the grandchild developed chicken pox (WAES # 1007USA01674). The patient stated that she developed chicken pox after being exposure to her grandchild. At the time of reporting, the outcome was unknown. It is unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.